Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

AIMS: VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) undergoing catheter ablation (CA). METHODS AND RESULTS: Trial size was administratively set at 250, the protocol-specified...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Heart J
Main Authors: Cappato, Riccardo, Marchlinski, Francis E., Hohnloser, Stefan H., Naccarelli, Gerald V., Xiang, Jim, Wilber, David J., Ma, Chang-Sheng, Hess, Susanne, Wells, Darryl S., Juang, George, Vijgen, Johan, Hügl, Burkhard J., Balasubramaniam, Richard, De Chillou, Christian, Davies, D. Wyn, Fields, L. Eugene, Natale, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
FASTTrack Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508487/
https://ncbi.nlm.nih.gov/pubmed/25975659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv177
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados